☰

Daniel J. Devine, Ph.D. - Publications

Affiliations: 
2012 College of Medicine University of South Alabama, Mobile, AL, United States 
Area:
Cell Biology, Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Valiunas V, Gordon C, Valiuniene L, Devine D, Lin RZ, Cohen IS, Brink PR. Intercellular delivery of therapeutic oligonucleotides. Journal of Drug Delivery Science and Technology. 72. PMID 36721641 DOI: 10.1016/j.jddst.2022.103404  0.325
2018 Drummond CJ, Hanna JA, Garcia MR, Devine DJ, Heyrana AJ, Finkelstein D, Rehg JE, Hatley ME. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell. 33: 108-124.e5. PMID 29316425 DOI: 10.1016/J.Ccell.2017.12.001  0.339
2018 Drummond CJ, Hanna JA, Garcia MR, Devine D, Peters J, Frohlich V, Finkelstein D, Hatley ME. Abstract A16: Fusion-negative rhabdomyosarcoma originating from endothelial progenitors Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A16  0.389
2018 Drummond CJ, Hanna JA, Garcia MR, Devine DJ, Heyrana AJ, Finkelstein D, Rehg JE, Hatley ME. Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-Pr12  0.411
2017 Drummond CJ, Garcia MR, Devine DJ, Peters J, Frohlich V, Finkelstein D, Hatley ME. Abstract 1036: Non-myogenic origin of embryonal rhabdomyosarcoma Cancer Research. 77: 1036-1036. DOI: 10.1158/1538-7445.Am2017-1036  0.405
2016 Pruitt HC, Devine DJ, Samant RS. Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination. International Journal of Cancer. 139: 491-500. PMID 26874464 DOI: 10.1002/Ijc.30043  0.647
2016 Drummond CJ, Devine D, Garcia MR, Hatley ME. Abstract IA03: Insights into the origins and pathogenesis of embryonal rhabdomyosarcoma Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-Ia03  0.383
2014 Rostas JW, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS. microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. Molecular Cancer. 13: 200. PMID 25174825 DOI: 10.1186/1476-4598-13-200  0.638
2014 Devine DJ, Rostas JW, Metge BJ, Das S, Mulekar MS, Tucker JA, Grizzle WE, Buchsbaum DJ, Shevde LA, Samant RS. Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling. Oncogene. 33: 2620-8. PMID 23770854 DOI: 10.1038/Onc.2013.215  0.667
2014 Pruitt HC, Rostas JW, Metge BJ, Devine DJ, Bailey SK, Shevde LA, Samant R. Abstract 4010: MicroRNA regulator of NMI: implications for breast cancer Cancer Research. 74: 4010-4010. DOI: 10.1158/1538-7445.Am2014-4010  0.662
2013 Samant RS, Devine DJ, Rostas JW, Metge BJ, Shevde LA. Abstract C28: N-Myc interactor: A gatekeeper of malignant progression Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C28  0.702
2012 Vincent AJ, Ren S, Harris LG, Devine DJ, Samant RS, Fodstad O, Shevde LA. Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. Febs Letters. 586: 3429-34. PMID 22858377 DOI: 10.1016/J.Febslet.2012.07.063  0.605
2012 Menezes ME, Devine DJ, Shevde LA, Samant RS. Dickkopf1: a tumor suppressor or metastasis promoter? International Journal of Cancer. 130: 1477-83. PMID 21953410 DOI: 10.1002/Ijc.26449  0.625
2011 Devine DJ, Andrews J, Rostas J, Shevde LA, Samant RS. Abstract 967: N-Myc interactor, a novel regulator of EMT Cancer Research. 71: 967-967. DOI: 10.1158/1538-7445.Am2011-967  0.69
Show low-probability matches.